PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50124C00040Lung-brain inflammatory NEXUS — University of Rochester

University of Rochester holds $16.5M across 56 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

University of Rochester

Recipient

Sep 29, 2026

PoP end

$4.3M

Obligated

$7.1M

Potential

541715

NAICS

AN13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs University of Rochester — $90

Contract facts

NONE

Contract number75A50124C00040

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentUniversity of Rochester

CAGE03CZ7

UEIF27KDXZMF9Y8

NAICS541715

PSCAN13

Place of performanceROCHESTER NY

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 1, 2024

PoP end (current)Sep 29, 2026

PoP end (w/ options)Oct 31, 2027

Obligated$4.3M

Current value$4.3M

Potential value$7.1M

LUNG-BRAIN INFLAMMATORY NEXUS: MICROPHYSIOLOGICAL SYSTEM, UNIVERSITY OF ROCHESTER is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by University of Rochester. Estimated value $7.1M ($4.3M obligated). Current period of performance ends Sep 29, 2026 (potential Oct 31, 2027). Last award drew 1 bidder. Place of performance: ROCHESTER NY.

LUNG-BRAIN INFLAMMATORY NEXUS: MICROPHYSIOLOGICAL SYSTEM, UNIVERSITY OF ROCHESTER

Recompete timing

Public

● Expiring in 39 days

Current PoP ends Sep 29, 2026 (39 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

University of Rochester — $16.5M obligated across 56 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($16.5M) · all agencies

Department of Defense (DOD)$10.6M · 64%Department of Health and Human Services (HHS)$4.3M · 26%Department of Veterans Affairs (VA)$1.5M · 9%

Related awards

Same incumbent

36C24226N0261

DERMATOLOGY PHYSICIAN SERVICES

$273K

Nov 30, 2026

W81XWH22C0138

RESEARCH AND DEVELOPMENT CONTRACT RESULTING FROM BROAD AGENCY ANNOUNCEMENT. PROPOSAL TP210…

$6.0M

Sep 18, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50124C00040?

75A50124C00040 (Lung-brain inflammatory NEXUS) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $7.1M, currently held by University of Rochester. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50124C00040?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50124C00040 to University of Rochester (potential $7.1M).

Who is the incumbent on 75A50124C00040?

University of Rochester is the incumbent with $16.5M across 56 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does University of Rochester’s 75A50124C00040 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 30, 2025